Antenatal corticosteroids and outcomes in gastroschisis: A multicenter retrospective cohort study

Helen Carnaghan1, Catherine P James2, Paul B Charlesworth3

  • 1UCL Great Ormond Street Institute of Child Health and Great Ormond Street Hospital for Children, London, UK.

Prenatal Diagnosis
|May 14, 2020
PubMed

Insights

Maternal antenatal corticosteroids did not improve gut function in infants with gastroschisis. This study found no significant effect on the time to full enteral feeds for these newborns.

Area of Science:

  • Neonatalogy
  • Pediatric Surgery
  • Maternal-Fetal Medicine

Background:

  • Gastroschisis is a congenital condition often associated with gut dysfunction.
  • Gut dysfunction in gastroschisis may develop secondary to bowel inflammation.

Purpose of the Study:

  • To evaluate the effect of maternal antenatal corticosteroids on time to full enteral feeds in infants with gastroschisis.
  • To assess if antenatal steroid administration impacts neonatal outcomes in gastroschisis.

Main Methods:

  • A multicenter retrospective cohort study of 500 infants with gastroschisis.
  • Primary outcome: time to full enteral feeds. Secondary outcome: length of hospital stay.
  • Statistical analysis included Mann-Whitney and Cox regression.

Main Results:

  • Antenatal corticosteroids showed no significant effect on reaching full enteral feeds (HR 1.0 [95% CI: 0.8-1.4]).
  • Complex gastroschisis was associated with increased time to full feeds (HR 0.3 [95% CI: 0.2-0.4]).
  • Later gestational age at birth correlated with faster achievement of full feeds.

Conclusions:

  • Maternal antenatal corticosteroid use, per current protocols, does not improve neonatal outcomes in gastroschisis.
  • The study did not find antenatal steroids to be associated with improved time to full enteral feeds or reduced hospital stay.
Abstract